Valanafusp alfa

DB15336InvestigationalProtein Based Therapies

Valanafusp alfa is under investigation in clinical trial NCT03071341 (Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I).

Mechanism: Pharmacologically active on Insulin receptor and Alpha-L-iduronidase
Curator reviewed
Code names: AGT-181

Resolves to

Compound

UNIIML78ZA3RNCCAS1815583-32-4

Targets

P06213INSRP35475IDUA

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Valanafusp alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account